SciSparc (SPRC) Enterprise Value (2016 - 2025)
SciSparc (SPRC) posted Enterprise Value of -$4.6 million for Q4 2025, down 443.96% sequentially from -$844000.0 in Q2 2025, and down 260.93% YoY from $2.9 million in Q4 2024.
SciSparc (SPRC) Enterprise Value (2016 - 2025) Analysis & Trends
SciSparc has reported Enterprise Value for 10 years, with the latest figure at -$4.6 million in Q4 2025.
- Quarterly Enterprise Value fell 260.93% year-over-year to -$4.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.6 million (down 260.93% YoY) and the FY2025 annual result came in at -$4.6 million, down 260.93% from the prior year.
- Enterprise Value eased to -$4.6 million in Q4 2025 per SPRC's latest filing, from -$844000.0 in the prior quarter.
- Over five years, Enterprise Value peaked at -$824000.0 in Q2 2024 and troughed at -$26.6 million in Q2 2022.
- A 5-year average of -$6.7 million and a median of -$3.2 million in 2023 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2021 and 2023: Enterprise Value slumped 8240.66% in 2021, then jumped 88.05% in 2023.
- Over 5 years, Enterprise Value stood at -$16.4 million in 2021, then jumped by 87.32% to -$2.1 million in 2022, then tumbled by 49.61% to -$3.1 million in 2023, then jumped by 59.01% to -$1.3 million in 2024, then plunged by 260.93% to -$4.6 million in 2025.
- According to Business Quant data, Enterprise Value over the past three periods registered -$4.6 million, -$844000.0, and -$1.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | SciSparc | 836,385.99 | 836,385.99 | - | -4.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -4.59 Mn |
| Jun 30, 2025 | -844,000.00 |
| Dec 31, 2024 | -1.27 Mn |
| Jun 30, 2024 | -824,000.00 |
| Dec 31, 2023 | -3.10 Mn |
| Jun 30, 2023 | -3.18 Mn |
| Dec 31, 2022 | -2.07 Mn |
| Sep 30, 2022 | -7.56 Mn |
| Jun 30, 2022 | -26.59 Mn |
| Dec 31, 2021 | -16.35 Mn |
| Jun 30, 2021 | -7.59 Mn |
| Dec 31, 2020 | -4.19 Mn |
| Jun 30, 2020 | -91,000.00 |
| Dec 31, 2019 | -870,000.00 |
| Jun 30, 2019 | -1.59 Mn |
| Mar 31, 2019 | -2.58 |
| Dec 31, 2018 | -1.59 Mn |
| Sep 30, 2018 | -2.04 Mn |
| Jun 30, 2018 | -5.13 Mn |
| Mar 31, 2018 | -7.53 Mn |